Sunshine Biopharma Inc. (SBFM)
NASDAQ · Healthcare
Sunshine Biopharma Inc. EBITDA 2017–2025
Sunshine Biopharma Inc. annual/quarterly ebitda history and growth rate from 2017 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Sunshine Biopharma Inc. ebitda for the quarter ending March 31, 2026 was -1.3 M, a 7.13% increase year-over-year.
- Sunshine Biopharma Inc. ebitda for the twelve months ending March 31, 2026 was -5.7 M, a 107.35% increase year-over-year.
- Sunshine Biopharma Inc. annual ebitda for 2025 was -5.9 M, a 5.48% increase from 2024.
- Sunshine Biopharma Inc. annual ebitda for 2024 was -5.6 M, a 20.54% increase from 2023.
- Sunshine Biopharma Inc. annual ebitda for 2023 was -4.6 M, a 82.81% decrease from 2022.
- Sunshine Biopharma Inc. annual ebitda for 2022 was -27.0 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Sunshine Biopharma Inc. EBITDA — FAQ
Sunshine Biopharma Inc. (SBFM) ebitda over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SBFM's ebitda history?
The chart and table above show Sunshine Biopharma Inc.'s ebitda by year and by quarter, including the growth rate.